Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Blue Ox Healthcare Partners

Investor type Private Equity Firm
Founders Oded Levy Sheila H. Schweitzer

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$41M
Portfolio companies 4
Rounds per year 0.43
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.33
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Hospital
  • Health Diagnostics
  • Medical
Summary

The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the New York.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Blue Ox Healthcare Partners, startups are often financed by Domain Associates, RMI Partners, Catalyst Health Ventures. The meaningful sponsors for the fund in investment in the same round are Viventures, Varian, Sabby Management.

Among the most popular fund investment industries, there are Health Diagnostics, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Epic Sciences.

The high activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in less than 2 deals every year.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelr8 Boston, Massachusetts, United States
Anthem Capital Management Baltimore, Maryland, United States
CM Venture Capital China, Shanghai
Genesis Financial -
Haitun Baobao China, Guangdong, Shenzhen
Laetitia Garriott de Cayeux New York, New York, United States
Neoteric Infomatique India, Maharashtra, Mumbai
Renren Inc. Chaoyang, China, Liaoning
SGR Investments -
Tamar Capital New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Gemelli Biotech

Biotechnology
Health Diagnostics
Pharmaceutical
$19M22 Jun 2022 Raleigh, North Carolina, United States

Epic Sciences

Biotechnology
Health Care
Health Diagnostics
Hospital
$43M01 Jun 2022 San Diego, California, United States

Sera Prognostics

Biotechnology
Health Care
Hospital
Medical
Medical Device
$100M28 Apr 2021 Salt Lake City, Utah, United States

Sera Prognostics

Biotechnology
Health Care
Hospital
Medical
Medical Device
$36M13 Nov 2019 Salt Lake City, Utah, United States

Epic Sciences

Biotechnology
Health Care
Health Diagnostics
Hospital
$52M12 Sep 2018 San Diego, California, United States

Health Care
06 Feb 2018 Boynton Beach, Florida, United States
News
Sera Prognostics Completes $100M Series E Financing

– Sera Prognostics, Inc. from Salt Lake City develops a blood-based biomarker test to predict the risk of preterm birth.
– Series E $100m round brings company valuation to more than $1b.
– The round was led by Vivo Capital, aMoon Fund, Parian Global and others, with participation from existing investors Anthem, Inc., and Blue Ox Healthcare Partners.
– The new investment will be aimed at commercializing its PreTRM® testing, accelerating the development of its pipeline of biomarker tests to predict other major conditions of pregnancy, and developing testing capacity for over 3 million annual pregnancies that are candidates for its PreTRM® Test in the United States.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Blue Ox Healthcare Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: